Gaps in the drug-free and methadone treatment program response to Hepatitis C

Shiela M. Strauss, Janetta Astone, Zdravko P. Vassilev, Don C. Des Jarlais, Holly Hagan

Research output: Contribution to journalArticlepeer-review


Drug treatment programs are sites of opportunity for the delivery of hepatitis C (HCV) prevention and care services to drug users. Using data collected from a random nationwide sample (N = 595) of drug treatment programs in the United States, this study compares the provision of HCV services by drug-free and methadone maintenance treatment programs (MMTPs). It then examines and compares perceived inadequacies in this service provision from the perspective of the managers in these two types of programs. Findings indicate that MMTPs are providing more HCV services to their patients, and that a greater proportion of MMTPs are dissatisfied with their current level of HCV service provision. Managers of drug-free programs would like to be offering patients more HCV education, while MMTP managers would like to be providing more HCV testing to their patients, and more support and care for patients who are HCV+.

Original languageEnglish (US)
Pages (from-to)291-297
Number of pages7
JournalJournal of Substance Abuse Treatment
Issue number4
StatePublished - Jun 2003


  • Disease prevention
  • Drug treatment programs
  • HCV services
  • Methadone maintenance
  • Telephone survey

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health


Dive into the research topics of 'Gaps in the drug-free and methadone treatment program response to Hepatitis C'. Together they form a unique fingerprint.

Cite this